COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 597: Articles 5961-5970  | Next

SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3
Schindewolf, C., Lokugamage, K., Vu, M., Johnson, B. A., Scharton, D., Plante, J. A., Kalveram, B. K., Crocquet-Valdes, P. A., Sotcheff, S. L., Jaworski, E., Alvarado, R. E., Debbink, K., Daugherty, M. D., Weaver, S., Routh, A. L., Walker, D. H., Plante, K. S., Menachery, V. D.
10.1101/2022.09.26.509529 — Posted: 2022-09-26
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against Omicron
Chi, X., Xia, L., Zhang, G., Chi, X., Huang, B., Zhang, Y., Chen, Z., Han, J., Wu, L., Li, Z., Sun, H., Huang, P., Yu, C., Chen, W., Zhou, Q.
10.1101/2022.09.25.509344 — Posted: 2022-09-26
Nanobodies for the treatment of SARS-CoV-2 in animals: a meta-analysis
jiao, j., lin, s. l., liang, z. q., Wu, P.
10.1101/2022.09.26.509459 — Posted: 2022-09-26
Zymosan-induced leukocyte and cytokine changes in pigs: a new model for streamlined drug testing against severe COVID-19
Kokeny, G., Bakos, T., Barta, B. A., Nagy, G. V., Meszaros, T., Kozma, G. T., Szabo, A., Szebeni, J., Merkely, B., Radovits, T.
10.1101/2022.09.23.509252 — Posted: 2022-09-26
Spatial transcriptomic profiling of coronary endothelial cells in SARS-CoV-2 myocarditis
Margaroli, C., Benson, P., Gastanadui, M. G., Song, C., Viera, L., Xing, D., Wells, J. M., Patel, R., Gaggar, A., Payne, G. A.
10.1101/2022.09.25.509426 — Posted: 2022-09-26
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
Tan, T. J. C., Mou, Z., Lei, R., Ouyang, W. O., Yuan, M., Song, G., Andrabi, R., Wilson, I. A., Kieffer, C., Dai, X., Matreyek, K. A., Wu, N. C.
10.1101/2022.09.24.509341 — Posted: 2022-09-26
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
Carter, B., Huang, P., Liu, G., Liang, Y., Lin, P. J. C., Peng, B.-H., McKay, L., Dimitrakakis, A., Hsu, J., Tat, V., Saenkham-Huntsinger, P., Chen, J., Kaseke, C., Gaiha, G. D., Xu, Q., Griffiths, A., Tam, Y. K., Tseng, C.-T. K., Gifford, D. K.
10.1101/2022.09.23.509206 — Posted: 2022-09-26
PF-D-Trimer, a broadly protective SARS-CoV-2 subunit vaccine: immunogenicity and application
Zhang, Z., Zhou, J., Ni, P., Hu, B., Deng, S., Xiao, Q., He, Q., Li, G., Xia, Y., Liu, M., Wang, C., Fang, Z., Xia, N., Zhang, Z.-R., Zhang, B., Cai, K., Jolicoeur, N., Xu, Y., Liu, B.
10.1101/2022.09.26.509414 — Posted: 2022-09-26
Post COVID-19 condition after Wildtype, Delta, and Omicron variant SARS-CoV-2 infection and vaccination: pooled analysis of two population-based cohorts
Ballouz, T., Menges, D., Kaufmann, M., Amati, R., Frei, A., von Wyl, V., Fehr, J. S., Albanese, E., Puhan, M. A.
10.1101/2022.09.25.22280333 — Posted: 2022-09-26
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the Omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study.
Gonzalez, S., Olszevicki, S., Gaiano, A., Salazar, M., Regairaz, L., Varela Baino, A. N., Bartel, E., Varela, T., Gonzalez Martinez, V., Pesci, S., Marin, L., Irassar, J. I., Ceriani, L., Garcia, E., Kreplak, N., Estenssoro, E., Marsico, F.
10.1101/2022.09.25.22280341 — Posted: 2022-09-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).